Maria T Millan
Affiliation: Stanford University
- One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experienceMaria T Millan
Stanford University School of Medicine, Palo Alto, CA 94304, USA
Transplantation 76:1458-63. 2003..Although others have reported on overall results of transplantation for PH1 covering a wide age spectrum, none has specifically addressed the high-risk infantile form of the disease...
- Tolerance and chimerism after renal and hematopoietic-cell transplantationJohn D Scandling
Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA
N Engl J Med 358:362-8. 2008..Adverse events requiring hospitalization were limited to a 2-day episode of fever with neutropenia. The patient has had neither rejection episodes nor clinical manifestations of graft-versus-host disease...
- Liver allografts are toleragenic in rats conditioned with posttransplant total lymphoid irradiationKazuhito Nagasaki
Department of Surgery, Division of Transplantation, Stanford University School of Medicine, Stanford, CA, USA
Transplantation 84:619-28. 2007..Posttransplant total lymphoid irradiation (TLI) treatment has been applied to tolerance induction protocols in heart and kidney transplantation models...
- Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantationMelissa Hurwitz
Department of Pediatrics, Stanford University, Palo Alto, CA 94304, USA
Pediatr Transplant 8:267-72. 2004..Episodes of rejection that occur after stopping IMS can be successfully treated with standard therapy without graft loss to acute rejection...
- Dual-kidney transplantation with organs from expanded criteria donors: a long-term follow-upJane C Tan
Kidney and Pancreas Transplant Program, Stanford University Medical Center, 750 Welch Road, Palo Alto, CA 94304 1509, USA
Transplantation 78:692-6. 2004..We now have 8-year follow-up in the first recipients. Older individuals were offered this option preferentially, because we reasoned that they would stand to benefit most from the shorter waiting period...
- Approaches to transplantation tolerance in humansSamuel Strober
Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305 5166, USA
Transplantation 77:932-6. 2004..Preclinical and clinical studies of the use of total lymphoid irradiation for the induction of chimeric and nonchimeric tolerance are summarized here...
- Cell-based therapies for metabolic liver diseaseGregory M Enns
Division of Medical Genetics, Department of Pediatrics, Lucile Packard Children s Hospital, Stanford University, Stanford, CA, 94305 5208, USA
Mol Genet Metab 95:3-10. 2008..Cell-based therapies, including those based on stem cells or more differentiated progenitor cells, may represent the future of cell transplantation for treatment of metabolic liver disease...
- Isolation and transcriptional profiling of purified hepatic cells derived from human embryonic stem cellsEric Chiao
Stanford University, Palo Alto, California, USA
Stem Cells 26:2032-41. 2008..Disclosure of potential conflicts of interest is found at the end of this article...
- Epstein-Barr virus latent membrane protein 1 activates nuclear factor-kappa B in human endothelial cells and inhibits apoptosisAnming Xiong
Department of Surgery, Stanford University School of Medicine, Stanford, CA 94304, USA
Transplantation 78:41-9. 2004..In this report, we determined the effect of latent EBV infection on endothelial cell activation and apoptosis...
- Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantationMaria T Millan
Department of Surgery, Division of Transplantation, Stanford University School of Medicine, Stanford, CA 94305, USA
Transplantation 73:1386-91. 2002....